Medical Digest & Congress Report

Joran Schoorlemmer presents the results of model validation and the clinical impact of adaptive recurrence risk predictions, focusing on how these tools can optimise follow-up strategies for prostate cancer at the EAU 2026 Annual Congress.

Video: https://medicaldigest.org/scientific-contents/interview:adaptive-recurrence-risk-predictions-optimise-prostate-cancer-follow-results-model-validation-and-clinical-impact

Professor Yair Lotan examines the clinical utility and future potential of urine biomarkers, focusing on how they are transforming the early detection and surveillance of bladder cancer at the EAU 2026 Annual Congress.

Video: https://medicaldigest.org/scientific-contents/interview:role-urine-biomarkers-detection-bladder-cancer

Professor Ashkan Mortezavi provides a comprehensive overview of the most significant recent and ongoing clinical trials in bladder and prostate cancer, highlighting their impact on future treatment standards at the EAU 2026 Annual Congress.

Video: https://medicaldigest.org/scientific-contents/interview:urology-trials-bladder-and-prostate-cancer

Professor Nikhil Vasdev explores the latest advancements in bladder cancer management, focusing on clinical trials, innovative surgical techniques, and the use of predictive tools at the EAU 2026 Annual Congress.

Video: https://medicaldigest.org/scientific-contents/interview:cutting-edge-strategies-bladder-cancer-trials-techniques-and-predictive-tools

Professor Alessandro Viti discusses the impact of PSMA-PET restaging on disease classification and management, redefining "EMBARK-like" patients in the modern PSMA era at the EAU 2026 Annual Congress.

Video: https://medicaldigest.org/scientific-contents/interview:redefining-embark-patients-psma-era-impact-psma-pet-restaging-disease-classification-and-management

Karen Middelbo Buch-Olsen and Mads Hvid Poulsen present the highly anticipated results from the PRISMA PET randomized controlled trial, comparing progression-free survival in prostate cancer staging between [¹⁸F]PSMA-1007 PET/ceCT and Na[¹⁸F]F-PET/ceCT at the EAU 2026 Annual Congress.

Video: https://medicaldigest.org/scientific-contents/interview:progression-free-survival-following-primary-staging-fpsma-1007-petcect-versus-naff-petcect-prostate-cancer-results-prisma-pet-randomized-controlled-trial

Professor Arjun Konath Nambiar provides a critical update on the 2026 EAU Guidelines, exploring the latest changes and ongoing controversies in urolithiasis, male and female LUTS, and urological infections at the EAU 2026 Annual Congress.

Video: https://medicaldigest.org/scientific-contents/interview:2026-eau-guidelines-update-and-controversies-urolithiasis-female-and-male-luts-and-infections-what-has-changed

Professor Florian M. E. Wagenlehner discusses the critical role of prophylactic antibiotics in renal cancer surgery and effective strategies for safeguarding patients from postoperative infections at the EAU 2026 Annual Congress.

Video: https://medicaldigest.org/scientific-contents/interview:infections-prophylactic-antibiotics-renal-cancer-surgery-safeguarding-patients-postoperative-infection

Professor Merel M.C. Lambregts discusses the delicate clinical challenge of antibiotics and renal health, exploring how to strike the perfect balance between therapeutic benefit and potential risk at the EAU 2026 Annual Congress.

Video: https://medicaldigest.org/scientific-contents/interview:antibiotics-renal-health-striking-perfect-balance-between-benefit-and-risk

Professor Andreas Røder discusses the evolving landscape and strategic shifts navigating the future of urologic care at the EAU 2026 Annual Congress.

Video: https://medicaldigest.org/scientific-contents/interview:navigating-future-urologic-care